Azalea Health’s Inpatient EHR, ChartAccess® 5.0, was 2014 edition certified under Drummond Group’s Electronic Health Records Office of the National Coordinator Authorized Certification Body (ONC-ACB) program on 06/30/2016.
Drummond Group’s ONC-ACB certification program certifies that EHRs meet the meaningful use criteria for either eligible provider or hospital technology. In turn, healthcare providers using the EHR systems of certified vendors are qualified to receive federal stimulus monies upon demonstrating meaningful use of the technology.

Unique certification numberCHPL ID:

Criteria to which ChartAccess® is certified:
170.314 (a)(1): Computerized provider order entry
170.314 (a)(2): Drug-drug, drug-allergy interactions checks
170.314 (a)(3): Demographics
170.314 (a)(4): Vital signs, body mass index, and growth Charts  
170.314 (a)(5): Problem list
170.314 (a)(6): Medication list
170.314 (a)(7): Medication allergy list
170.314 (a)(8): Clinical decision support
170.314 (a)(9): Electronic notes
170.314 (a)(10): Drug formulary checks
170.314 (a)(11): Smoking status
170.314 (a)(12): Image results
170.314 (a)(13): Family health history
170.314 (a)(14): Patient list creation
170.314 (a)(15): Patient-specific education resources
170.314 (a)(16): Inpatient setting only – electronic medication administration record
170.314 (a)(17): Advance directives
170.314 (a)(18): Optional – computerized provider order entry – medications
170.314 (a)(19): Optional – computerized provider order entry – laboratory
170.314 (a)(20): Optional – computerized provider order entry – diagnostic imaging
170.314 (b)(1): Transitions of care – receive, display and incorporate transition of care/referral summaries
170.314 (b)(2): Transitions of care – create and transmit transition of care/referral summaries
170.314 (b)(3): Electronic prescribing
170.314 (b)(4): Clinical information reconciliation
170.314 (b)(5)(B): Incorporate laboratory tests and values/results
170.314 (b)(6): Inpatient setting only – transmission of electronic laboratory tests and values/results to ambulatory providers
170.314 (b)(7): Data portability
170.314 (c)(1): Clinical quality measures – capture and export
170.314 (c)(2): Clinical quality measures – import and calculate
170.314 (c)(3): Clinical quality measures – electronic submission
170.314 (d)(1): Authentication, access, control, and authorization
170.314 (d)(2): Auditable events and tamper-resistance
170.314 (d)(3): Audit report(s)
170.314 (d)(4): Amendments
170.314 (d)(5): Automatic log-off
170.314 (d)(6): Emergency access
170.314 (d)(7): End-user device encryption
170.314 (d)(8): Integrity
170.314 (e)(1): View, download, and transmit to a 3rd party with edge protocol testing
170.314 (f)(1): Immunization information
170.314 (f)(2): Transmission to immunization registries
170.314 (f)(3): Transmission to public health agencies – syndromic surveillance
170.314 (f)(4): Inpatient setting only – transmission of reportable laboratory tests and values/results
170.314 (g)(2): Automated measure calculation
170.314 (g)(3): Safety-enhanced design
170.314 (g)(4): Quality management system  


Clinical Quality Measures to which ChartAccess® is certified:

CMS9: Exclusive Breast Milk Feeding
CMS26: Home Management Plan of Care (HMPC) Document Given to Patient/Caregiver
CMS30: Statin Prescribed at Discharge
CMS31: Hearing Screening Prior To Hospital Discharge
CMS32: Median Time from ED Arrival to ED Departure for Discharged ED Patients
CMS53: Primary PCI Received Within 90 Minutes of Hospital Arrival
CMS55: Median Time from ED Arrival to ED Departure for Admitted ED Patients
CMS60: Fibrinolytic Therapy Received Within 30 Minutes of Hospital Arrival
CMS71: Anticoagulation Therapy for Atrial Fibrillation/Flutter
CMS72: Antithrombotic Therapy By End of Hospital Day 2
CMS73: Venous Thromboembolism Patients with Anticoagulation Overlap Therapy
CMS91: Thrombolytic Therapy
CMS100: Aspirin Prescribed at Discharge
CMS102: Assessed for Rehabilitation
CMS104: Discharged on Antithrombotic Therapy
CMS105: Discharged on Statin Medication
CMS107: Stroke Education
CMS108: Venous Thromboembolism Prophylaxis
CMS109: Venous Thromboembolism Patients Receiving Unfractionated Heparin with Dosages/Platelet Count Monitoring by Protocol or Nomogram
CMS110: Venous Thromboembolism Discharge Instructions
CMS111: Median Admit Decision Time to ED Departure Time for Admitted Patients
CMS113: Elective Delivery
CMS114: Incidence of Potentially-Preventable Venous Thromboembolism
CMS171: Prophylactic Antibiotic Received Within One Hour Prior to Surgical Incision
CMS172: Prophylactic Antibiotic Selection for Surgical Patients
CMS178: Urinary catheter removed on Postoperative Day 1 (POD 1) or Postoperative Day 2 (POD 2) with day of surgery being day zero
CMS185: Healthy Term Newborn
CMS188: Initial Antibiotic Selection for Community-Acquired Pneumonia (CAP) in Immunocompetent Patients
CMS190: Intensive Care Unit Venous Thromboembolism Prophylaxis


Additional software use demonstrate compliance with certification criteria:

DrFirst Rcopia, Intelichart, ExitCare


ONC Disclaimer:

This EHR is 2014 Edition compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.  

Costs & Limitations Transparency:

Upfront costs:

  • Tiered software licensing based on provider or bed quantity at time of purchase
  • Implementation and Training services
  • Basic Support and Maintenance services
  • Hosting or Hardware costs as defined by licensing model

Additional fees which may be incurred include:

  • Training beyond the scope of the original implementation
  • Consulting services for meeting regulatory requirements
  • Level II support services beyond the scope of the licensed product
    • e.g.: infrastructure and network support
  • Maintenance release level updates outside of normal business hours
  • New Software Release Versions which were not included in initial Software licensing
  • New Modular Products not in initial software licensing.
  • New Interface development and maintenance beyond the scope of the original implementation
    • e.g.: interfaces to reporting registries for Meaningful Use measures or any other regulatory reporting
  • Implementation of additional peripheral and other hardware devices beyond the scope of the original implementation
    • e.g.: including but not limited to printers, mobile workstations, scanners, tablets, etc.
  • Prognosis Innovation Healthcare cloud backup solution
  • Software reconfiguration requests outside of the original scope of implementation
  • Revenue Cycle Management services

Costs which may be subject to escalation:

  • Annual support and maintenance fees
  • If applicable, annual hosting fees
  • If applicable, annual subscription fees
  • Annual third party fees such as ePrescribing, Practice Portal, Patient education content, Encoding, Insurance Eligibility and Advanced Beneficiary Notice which may be brokered through Prognosis Innovation Healthcare or contracted directly

Periodic charges for continual right to use of the software:

As defined by licensing model:

  • Tiered subscription pricing based on provider or bed quantity
  • Annual software Support and Maintenance for contracted software licensing


  • Use of the Patient Electronic Access Reporting out of the Patient Portal is limited to the following DirectTrust network HISPs at this time: MaxMD, Nitor Group.
  • If Public Health Reporting is achieved through an HIE then automated measure calculation of this measure may not be possible without new or additional Interface development.
  • Automated measure calculation of Patient Specific Education requires the use of a specific vendor
  • Automated measure calculation of Electronic Prescribing and refill requests requires the use of a specific vendor without a new or additional interface development.
  • On premise Customer facility installations of Prognosis systems must have the ability to connect to the Prognosis datacenter via an Internet connection to access certain features of the system.
  • Customer must establish a Virtual Private Network connection to Prognosis for Support Services to be activated.